1261982

Adare Pharmaceuticals, Inc. — FEI 1525864

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 25, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Vandalia, OH (United States)

Citations

IDCFRDescription
202721 CFR 211.192Investigations of discrepancies, failures